Literature DB >> 22280204

HIV type 1 infection up-regulates TLR2 and TLR4 expression and function in vivo and in vitro.

Juan C Hernández1, Mario Stevenson, Eicke Latz, Silvio Urcuqui-Inchima.   

Abstract

Toll-like receptors (TLRs) play a critical role in innate immunity against pathogens. Their stimulation induces the activation of NF-κB, an important inducer of HIV-1 replication. In recent years, an increasing number of studies using several cells types from HIV-infected patients indicate that TLRs play a key role in regulating the expression of proinflammatory cytokines and viral pathogenesis. In the present study, the effect of HIV-1 stimulation of monocyte-derived macrophage (MDM) and peripheral blood mononuclear cell (PBMC) subpopulations from healthy donors on the expression and functions of TLR2 and TLR4 was examined. In addition, and to complete the in vitro study, the expression pattern of TLR2 and TLR4 in 49 HIV-1-infected patients, classified according to viral load and the use of HAART, was determined and compared with 25 healthy subjects. An increase of TLR expression and production of proinflammatory cytokines were observed in MDMs and PBMCs infected with HIV-1 in vitro and in response to TLR stimulation, compared to the mock. In addition, an association between TLR expression and up-regulation of CD80 in plasmacytoid dendritic cells (pDCs) was observed. The ex vivo analysis indicated increased expression of TLR2 and TLR4 in myeloid dendritic cells (mDCs), but only of TLR2 in monocytes obtained from HIV-1-infected patients, compared to healthy subjects. Remarkably, the expression was higher in cells from patients who do not use HAART. In monocytes, there was a positive correlation between both TLRs and viral load, but not CD4(+) T cell numbers. Together, our in vitro and ex vivo results suggest that TLR expression and function can be up-regulated in response to HIV-1 infection and could affect the inflammatory response. We propose that modulation of TLRs represents a mechanism to promote HIV-1 replication or AIDS progression in HIV-1-infected patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22280204      PMCID: PMC3482876          DOI: 10.1089/aid.2011.0297

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  64 in total

Review 1.  CpG motifs in bacterial DNA and their immune effects.

Authors:  Arthur M Krieg
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

Review 2.  Inferences, questions and possibilities in Toll-like receptor signalling.

Authors:  Bruce Beutler
Journal:  Nature       Date:  2004-07-08       Impact factor: 49.962

3.  Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines.

Authors:  Kol A Zarember; Paul J Godowski
Journal:  J Immunol       Date:  2002-01-15       Impact factor: 5.422

4.  Toll-like receptor 2 (TLR2) and TLR9 signaling results in HIV-long terminal repeat trans-activation and HIV replication in HIV-1 transgenic mouse spleen cells: implications of simultaneous activation of TLRs on HIV replication.

Authors:  Ozlem Equils; Marco L Schito; Hiase Karahashi; Zeynep Madak; Ayse Yarali; Kathrin S Michelsen; Alan Sher; Moshe Arditi
Journal:  J Immunol       Date:  2003-05-15       Impact factor: 5.422

Review 5.  Regulation of dendritic cell function through Toll-like receptors.

Authors:  Tsuneyasu Kaisho; Shizuo Akira
Journal:  Curr Mol Med       Date:  2003-06       Impact factor: 2.222

6.  Bacterial lipopolysaccharide activates HIV long terminal repeat through Toll-like receptor 4.

Authors:  O Equils; E Faure; L Thomas; Y Bulut; S Trushin; M Arditi
Journal:  J Immunol       Date:  2001-02-15       Impact factor: 5.422

7.  Increased expression of toll-like receptor 2 on monocytes in HIV infection: possible roles in inflammation and viral replication.

Authors:  Lars Heggelund; Fredrik Müller; Egil Lien; Arne Yndestad; Thor Ueland; Knut Ivan Kristiansen; Terje Espevik; Pål Aukrust; Stig S Frøland
Journal:  Clin Infect Dis       Date:  2004-06-18       Impact factor: 9.079

8.  Signaling through Toll-like receptors triggers HIV-1 replication in latently infected mast cells.

Authors:  J Bruce Sundstrom; Dawn M Little; Francois Villinger; Jane E Ellis; Aftab A Ansari
Journal:  J Immunol       Date:  2004-04-01       Impact factor: 5.422

9.  HIV-1 Nef intersects the macrophage CD40L signalling pathway to promote resting-cell infection.

Authors:  Simon Swingler; Beda Brichacek; Jean-Marc Jacque; Catherine Ulich; Jin Zhou; Mario Stevenson
Journal:  Nature       Date:  2003-07-10       Impact factor: 69.504

10.  Acute modulation of toll-like receptors by insulin.

Authors:  Husam Ghanim; Priya Mohanty; Rupali Deopurkar; Ching Ling Sia; Kelly Korzeniewski; Sanaa Abuaysheh; Ajay Chaudhuri; Paresh Dandona
Journal:  Diabetes Care       Date:  2008-06-12       Impact factor: 19.112

View more
  33 in total

1.  HIV-1-neutrophil interactions trigger neutrophil activation and Toll-like receptor expression.

Authors:  Diana Marcela Giraldo; Juan Carlos Hernandez; Paula Velilla; Silvio Urcuqui-Inchima
Journal:  Immunol Res       Date:  2016-02       Impact factor: 2.829

2.  Chronic Viral Neuroinflammation: Speculation on Underlying Mechanisms.

Authors:  Elizabeth C Delery; Andrew G MacLean
Journal:  Viral Immunol       Date:  2018-09-27       Impact factor: 2.257

Review 3.  Inflammation-induced foam cell formation in chronic inflammatory disease.

Authors:  Thomas A Angelovich; Anna C Hearps; Anthony Jaworowski
Journal:  Immunol Cell Biol       Date:  2015-03-10       Impact factor: 5.126

4.  Persistent EcoHIV infection induces nigral degeneration in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-intoxicated mice.

Authors:  Katherine E Olson; Aditya N Bade; Krista L Namminga; Mary Jane Potash; R Lee Mosley; Larisa Y Poluektova; David J Volsky; Howard E Gendelman
Journal:  J Neurovirol       Date:  2018-03-28       Impact factor: 2.643

5.  MicroRNA miR-126-5p Enhances the Inflammatory Responses of Monocytes to Lipopolysaccharide Stimulation by Suppressing Cylindromatosis in Chronic HIV-1 Infection.

Authors:  Jun Huang; Lingyan Zhu; Chao Qiu; Xuan Xu; Linxia Zhang; Xiangqing Ding; Qibin Liao; Jianqing Xu; Xiaoyan Zhang
Journal:  J Virol       Date:  2017-04-28       Impact factor: 5.103

6.  HIV-1-derived single-stranded RNA acts as activator of human neutrophils.

Authors:  Diana M Giraldo; Juan C Hernandez; Silvio Urcuqui-Inchima
Journal:  Immunol Res       Date:  2016-12       Impact factor: 2.829

7.  HIV-1-exposed seronegative individuals show alteration in TLR expression and pro-inflammatory cytokine production ex vivo: An innate immune quiescence status?

Authors:  Juan C Hernandez; Georges St Laurent; Silvio Urcuqui-Inchima
Journal:  Immunol Res       Date:  2016-02       Impact factor: 2.829

Review 8.  APOL1 Renal Risk Variants: Fertile Soil for HIV-Associated Nephropathy.

Authors:  Jeffrey B Kopp; Jurgen Heymann; Cheryl A Winkler
Journal:  Semin Nephrol       Date:  2017-11       Impact factor: 5.299

9.  A role for TLR signaling during B cell activation in antiretroviral-treated HIV individuals.

Authors:  Basile Siewe; Ali Keshavarzian; Audrey French; Patricia Demarais; Alan Landay
Journal:  AIDS Res Hum Retroviruses       Date:  2013-08-16       Impact factor: 2.205

10.  Increased Escherichia coli-induced interleukin-23 production by CD16+ monocytes correlates with systemic immune activation in untreated HIV-1-infected individuals.

Authors:  Jennifer A Manuzak; Stephanie M Dillon; Eric J Lee; Zachary M Dong; Daniel K Hecht; Cara C Wilson
Journal:  J Virol       Date:  2013-09-25       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.